Portfolio Sync Solutions
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTEDPacific Biosciences of California, Inc. Analyst EPS Estimates
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|---|---|---|---|
| Q1 2025 | 8 | -$0.24 | -$0.15 | -$0.19 |
| Q2 2025 | 6 | -$0.20 | -$0.17 | -$0.19 |
| Q3 2025 | 4 | -$0.19 | -$0.16 | -$0.18 |
| Q4 2025 | 7 | -$0.19 | -$0.16 | -$0.18 |
| Q1 2026 | 3 | -$0.19 | -$0.16 | -$0.18 |
| Q2 2026 | 5 | -$0.18 | -$0.16 | -$0.17 |
| Q3 2026 | 3 | -$0.18 | -$0.15 | -$0.17 |
| Q4 2026 | 6 | -$0.17 | -$0.15 | -$0.16 |
| Q1 2027 | 3 | -$0.17 | -$0.15 | -$0.16 |
| Q2 2027 | 5 | -$0.16 | -$0.14 | -$0.15 |
| Q3 2027 | 3 | -$0.14 | -$0.12 | -$0.13 |
| Q4 2027 | 6 | -$0.13 | -$0.11 | -$0.12 |
Pacific Biosciences of California, Inc. Earnings Date And Information
Pacific Biosciences of California, Inc. last posted its earnings results on Thursday, February 13th, 2025. The company reported $-0.2 earnings per share for the quarter, missing analysts' consensus estimates of $-0.2 by $0. The company had revenue of 39.22 M for the quarter and had revenue of 154.01 M for the year. Pacific Biosciences of California, Inc. has generated $-1 earnings per share over the last year ($-1.07 diluted earnings per share) and currently has a price-to-earnings ratio of -1.17. Pacific Biosciences of California, Inc. has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, February 13th, 2025 based on prior year's report dates.
Pacific Biosciences of California, Inc. Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 02/13/2025 | Q4 2024 | -$0.20 | $0.01 | 0.21 | $40.10 M | $39.22 M |
| 11/08/2024 | Q3 2024 | N/A | -$0.22 | N/A | $41.95 M | $39.97 M |
| 08/08/2024 | Q2 2024 | N/A | -$0.64 | N/A | $40.88 M | $36.01 M |
| 05/09/2024 | Q1 2024 | -$0.26 | -$0.29 | -0.03 | $43.44 M | $38.81 M |
| 12/30/2023 | Q4 2023 | N/A | -$0.31 | N/A | $57.47 M | $58.36 M |
| 11/03/2023 | Q3 2023 | N/A | -$0.26 | N/A | $48.76 M | $55.69 M |
| 08/04/2023 | Q2 2023 | N/A | -$0.28 | N/A | $40.18 M | $47.57 M |
| 05/04/2023 | Q1 2023 | N/A | -$0.34 | N/A | $34.38 M | $38.90 M |
| 02/28/2023 | Q4 2022 | N/A | -$0.35 | N/A | N/A | $27.35 M |
| 11/08/2022 | Q3 2022 | N/A | -$0.37 | N/A | $35.40 M | $32.31 M |
| 08/05/2022 | Q2 2022 | N/A | -$0.32 | N/A | $35.16 M | $35.47 M |
| 05/05/2022 | Q1 2022 | N/A | -$0.38 | N/A | N/A | $33.17 M |
| 02/28/2022 | Q4 2021 | N/A | -$0.32 | N/A | N/A | $36.02 M |
| 11/04/2021 | Q3 2021 | N/A | $0.08 | N/A | $33.60 M | $34.89 M |
| 08/05/2021 | Q2 2021 | N/A | -$0.21 | N/A | $29.99 M | $30.61 M |
| 05/06/2021 | Q1 2021 | N/A | -$0.45 | N/A | N/A | $29.00 M |
| 02/26/2021 | Q4 2020 | N/A | $0.40 | N/A | N/A | $27.14 M |
| 11/02/2020 | Q3 2020 | N/A | -$0.14 | N/A | $20.33 M | $19.08 M |
| 08/06/2020 | Q2 2020 | N/A | -$0.15 | N/A | $13.72 M | $17.08 M |
| 05/08/2020 | Q1 2020 | N/A | $0.01 | N/A | N/A | $15.60 M |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Pacific Biosciences of California, Inc. Earnings: FAQ's
Pacific Biosciences of California, Inc. has not confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, February 13th, 2025 based offlast year's report dates.
The conference call for Pacific Biosciences of California, Inc.'s latest earnings report can be listened to online.
The conference call transcript for Pacific Biosciences of California, Inc.'s latest earnings report can be read online.
Pacific Biosciences of California, Inc. (:PACB) has a recorded annual revenue of $154.01 M.
Pacific Biosciences of California, Inc. (:PACB) has a recorded net income of $-308,651,000.Pacific Biosciences of California, Inc. has generated $-1.12 earnings per share over the last four quarters.
Pacific Biosciences of California, Inc. (:PACB) has a price-to-earnings ratio of -1.17 and price/earnings-to-growth ratio is -0.05.